Named Patient Use Program to Provide Abemaciclib for the Treatment of Metastatic Breast Cancer
Latest Information Update: 18 Dec 2024
At a glance
- Drugs Abemaciclib (Primary)
- Indications Advanced breast cancer
- Focus Expanded access; Therapeutic Use
- Sponsors Eli Lilly and Company
- 16 Dec 2024 Status changed from recruiting to completed.
- 12 Dec 2018 New trial record